MBAI:NASDAQ, Check-Cap Ltd.

MBAI stock overview

Check-Cap Ltd. (MBAI:NASDAQ) closed at $2.05 on November 17, 2026, down 0.97% on the day. The stock trades 92.5% below its 52-week high of $27.44 and 27.3% above its 52-week low of $1.61. Over the past year, it lost 79.8%. Check-Cap Ltd. is part of the Health Care sector.

Key figures

Price
$2.05
Day change
-0.97%
Volume
2,046
Average volume
23,567
Market cap
31M+
52-week range
$1.61 – $27.44
50-day average
$3.56
200-day average
$8.55

Price action over the past year

In 252 trading sessions since November 17, 2025, MBAI closed higher on 102 days (40%). Its best day was January 26, 2026 (+112.08%) and its worst was January 27, 2026 (-27.22%). The stock moved 10% or more in a single session 32 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

MBAI news

About Check-Cap Ltd.

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection.

Similar stocks

Find more stocks like MBAI with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.